Main menu

Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease


The immune mechanisms responsible for the protection provided by Oxford-AstraZeneca’s COVID-19 vaccine are still unclear, but are important to understand for future vaccine development. The authors revealed distinct immune responses between vaccinated individuals and placebo recipients, through nanopore transcriptome sequencing. These differences provide a mechanistic understanding to how the vaccine reduces disease severity, and highlight biomarkers for future vaccine research.

Authors: Ruth E. Drury, Susana Camara, Irina Chelysheva, Sagida Bibi, Katherine Sanders, Salle Felle, Katherine Emary, Daniel Phillips, Merryn Voysey, Daniela M. Ferreira, Paul Klenerman, Sarah C. Gilbert, Teresa Lambe, Andrew J. Pollard & Daniel O’Connor

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag